Molbio Diagnostics Limited (MOLBIO) fundamentals
Molbio Diagnostics Limited is a listed company, part of the Healthcare sector, listed on the NSE as MOLBIO (ISIN INE869T01028). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
Valuation and market data
| Last close | ₹1273.50 |
|---|---|
| Market capitalisation | ₹14,153 crore |
| Enterprise value | ₹14,099 crore |
| P/E (TTM) | 46.07 |
| Price to book | 10.81 |
| Price to sales (TTM) | 4.75 |
| Book value per share | ₹117.77 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | — |
| Listed since | Mon Aug 17 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,455 crore | ₹231 crore | ₹164 crore | 14.77 |
| Mar 2025 | ₹1,028 crore | ₹194 crore | ₹139 crore | 12.87 |
| Mar 2024 | ₹841 crore | ₹130 crore | ₹84 crore | 9.05 |
| Mar 2023 | ₹337 crore | ₹10 crore | ₹-3 crore | -0.06 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 41.3% |
|---|---|
| Foreign institutions (FII) | 1.6% |
| Mutual funds | 8.0% |
| Other domestic institutions | 11.1% |
| Retail and others | 38.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.